PlumX Metrics
Embed PlumX Metrics

Blood Pressure Control in Patients with Diabetic Kidney Disease

Electrolyte and Blood Pressure, ISSN: 2092-9935, Vol: 20, Issue: 2, Page: 39-48
2022
  • 1
    Citations
  • 0
    Usage
  • 30
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease. Blood pressure (BP) control can reduce the risks of cardiovascular (CV) morbidity, mortality, and kidney disease progression. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines have suggested the implementation of a more intensive BP control with a target systolic BP (SBP) of <120 mmHg based on the evidence that the CV benefits obtained is outweighed by the kidney injury risk associated with a lower BP target. However, an extremely low BP level may paradoxically aggravate renal function and CV outcomes. Herein, we aimed to review the existing literature regarding optimal BP control using medications for DKD.

Bibliographic Details

Kim, Yaeni; Kim, Won; Kim, Jwa-Kyung; Moon, Ju Young; Park, Samel; Park, Cheol Whee; Park, Hoon Suk; Song, Sang Heon; Yoo, Tae-Hyun; Lee, So-Young; Lee, Eun Young; Lee, Jeonghwan; Jin, Kyubok; Cha, Dae Ryong; Cha, Jin Joo; Han, Sang Youb; Korean Diabetic Kidney Disease Working Group

The Korean Society of Electrolyte Metabolism

Medicine; Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know